Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer’s disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer’s disease
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 117, Issue 8, Pages 4418-4427
Publisher
Proceedings of the National Academy of Sciences
Online
2020-02-13
DOI
10.1073/pnas.1916895117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tauopathy: A common mechanism for neurodegeneration and Brain Aging
- (2019) Pampa Saha et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Synaptic dysfunction in Alzheimer's disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention
- (2018) Pavlos Alifragis et al. Neural Regeneration Research
- Reducing the Levels of Akt Activation by PDK1 Knock-in Mutation Protects Neuronal Cultures against Synthetic Amyloid-Beta Peptides
- (2018) Shaobin Yang et al. Frontiers in Aging Neuroscience
- Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
- (2018) Fuyuki Kametani et al. Frontiers in Neuroscience
- Linking Neuroinflammation and Neurodegeneration in Parkinson’s Disease
- (2018) Géraldine Gelders et al. Journal of Immunology Research
- Microglia and CNS Interleukin-1: Beyond Immunological Concepts
- (2018) Xiaoyu Liu et al. Frontiers in Neurology
- GSK3 in Alzheimer's Disease: Mind the Isoforms
- (2018) Tao Ma JOURNAL OF ALZHEIMERS DISEASE
- Neuroinflammatory Cytokines Induce Amyloid Beta Neurotoxicity through Modulating Amyloid Precursor Protein Levels/Metabolism
- (2018) Fawaz Alasmari et al. Biomed Research International
- Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer’s disease
- (2017) Ramesh Kandimalla et al. HUMAN MOLECULAR GENETICS
- Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer’s Disease
- (2017) Akio Kimura et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons
- (2017) Ravi Rajmohan et al. JOURNAL OF ALZHEIMERS DISEASE
- Functional and Molecular Insights of Hydrogen Sulfide Signaling and Protein Sulfhydration
- (2017) Nilkantha Sen JOURNAL OF MOLECULAR BIOLOGY
- Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review
- (2017) K E Hopperton et al. MOLECULAR PSYCHIATRY
- Tau-based therapies in neurodegeneration: opportunities and challenges
- (2017) Chuanzhou Li et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting PTEN interactions for Alzheimer's disease
- (2016) Samuel Frere et al. NATURE NEUROSCIENCE
- PTEN recruitment controls synaptic and cognitive function in Alzheimer's models
- (2016) Shira Knafo et al. NATURE NEUROSCIENCE
- Reduction of Nuak1 Decreases Tau and Reverses Phenotypes in a Tauopathy Mouse Model
- (2016) Cristian A. Lasagna-Reeves et al. NEURON
- How neuroinflammation contributes to neurodegeneration
- (2016) R. M. Ransohoff SCIENCE
- Abnormal tau induces cognitive impairment through two different mechanisms: synaptic dysfunction and neuronal loss
- (2016) J. Di et al. Scientific Reports
- Therapeutic benefits of H2S in Alzheimer’s disease
- (2014) Hai-Jun Wei et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Cytokine-Induced GAPDH Sulfhydration Affects PSD95 Degradation and Memory
- (2014) Sajad Mir et al. MOLECULAR CELL
- Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview
- (2014) Frederic Brosseron et al. MOLECULAR NEUROBIOLOGY
- Subcellular targeting and dynamic regulation of PTEN: implications for neuronal cells and neurological disorders
- (2014) Patricia Kreis et al. Frontiers in Molecular Neuroscience
- Developing Therapeutic Approaches to Tau, Selected Kinases, and Related Neuronal Protein Targets
- (2013) V. M.-Y. Lee et al. Cold Spring Harbor Perspectives in Medicine
- The Clinical Problem of Symptomatic Alzheimer Disease and Mild Cognitive Impairment
- (2013) R. Tarawneh et al. Cold Spring Harbor Perspectives in Medicine
- Roles of Glycogen Synthase Kinase 3 in Alzheimer’s Disease
- (2012) Zhiyou Cai et al. Current Alzheimer Research
- H2S signalling through protein sulfhydration and beyond
- (2012) Bindu D. Paul et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
- (2012) Jose Miguel Rubio-Perez et al. TheScientificWorldJOURNAL
- P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating
- (2011) Hiroki Takeuchi et al. PLoS One
- GSK-3: Functional Insights from Cell Biology and Animal Models
- (2011) Oksana Kaidanovich-Beilin et al. Frontiers in Molecular Neuroscience
- GSK3 and Alzheimer’s disease: facts and fiction…
- (2011) Anna Kremer Frontiers in Molecular Neuroscience
- A Meta-Analysis of Cytokines in Alzheimer's Disease
- (2010) Walter Swardfager et al. BIOLOGICAL PSYCHIATRY
- The pattern of human tau phosphorylation is the result of priming and feedback events in primary hippocampal neurons
- (2010) J. Bertrand et al. NEUROSCIENCE
- Alzheimer's disease: synaptic dysfunction and Aβ
- (2009) Ganesh M Shankar et al. Molecular Neurodegeneration
- H2S Signals Through Protein S-Sulfhydration
- (2009) A. K. Mustafa et al. Science Signaling
- Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
- (2008) C.-X. Gong et al. CURRENT MEDICINAL CHEMISTRY
- Memory loss in Alzheimer’s disease: implications for development of therapeutics
- (2008) Carl A Gold et al. Expert Review of Neurotherapeutics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started